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Abstract
Biomaterial injection is a potential new therapy for augmenting ventricular mechanics after 
myocardial infarction (MI). Recent in vivo studies have demonstrated that hydrogel injections can 
mitigate the adverse remodeling due to MI. More importantly, the material properties of these 
injections influence the efficacy of the therapy. The goal of the current study is to explore the 
interrelated effects of injection stiffness and injection volume on diastolic ventricular wall stress 
and thickness. To achieve this, finite element models were constructed with different hydrogel 
injection volumes (150 μL and 300 μL), where the modulus was assessed over a range of 0.1 kPa 
to 100 kPa (based on experimental measurements). The results indicate that a larger injection 
volume and higher stiffness reduce diastolic myofiber stress the most, by maintaining the wall 
thickness during loading. Interestingly, the efficacy begins to taper after the hydrogel injection 
stiffness reaches a value of 50kPa. This computational approach could be used in the future to 
evaluate the optimal properties of the hydrogel.
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1. Introduction
According to the American Heart Association, cardiovascular disease is the leading cause of 
death worldwide, accounting for more than 17.3 million deaths per year, and is projected to 
increase to more than 23.6 million by 2030 (Mozaffarian et al., 2016). Roughly 785,000 
people in the United States have a myocardial infarction (MI) each year, which can 
eventually lead to chronic heart failure due to adverse remodeling of the heart wall 
(Mozaffarian et al., 2016). As such, the material properties of myocardium are an important 
determinant of global left ventricular (LV) function in both health and disease. One potential 
treatment strategy being investigated is the use of biocompatible injectable materials as a 
means of alleviating adverse remodeling. Several formulations of injectable biomaterials 
have been studied in order to evaluate the impact on wall thickness and global LV function 
(Dorsey et al., 2015; Ifkovits et al., 2010; Morita et al., 2011; Tous et al., 2011). These in 
vivo studies have demonstrated that injectable hydrogel injections can mitigate the adverse 
effects of MI (Dorsey et al., 2015; Rodell et al., 2016).
Interestingly, the stiffness of these injections can be tuned to minimize wall thinning and 
ventricular dilation. Specifically, experimental studies with large animal models were 
conducted to investigate different hydrogel injections with altered stiffness characteristics, 
namely, one with a higher stiffness and another with a lower stiffness (Ifkovits et al., 2010; 
Rodell et al., 2016). The results showed a better ability to limit infarct expansion and 
remodeling with the higher stiffness hydrogel injection. Inspired by these studies, the current 
investigation combines experimental data and finite element (FE) modeling to better 
understand how hydrogel injection stiffness and volume influence myocardial wall stress 
and wall thickness. This was accomplished by using previously measured MRI data from 
explanted ovine LVs, which were injected with an array of hydrogel, in order to assess in 
vivo injection geometry. FE models were then constructed to represent various combinations 
of injection volume within the LV wall, over a range of hydrogel elastic moduli.
2. Methods
2.1 Finite Element Model
In order to evaluate the effects of various hydrogels, FE models of the LV with two different 
injection volumes (150 μL and 300 μL) were generated, as well as a control model with no 
injections. The reference configuration of each model was chosen to represent early diastole, 
since the stress in the LV is at a minimum. The LV FE meshes were produced using tri-linear 
hexahedral brick elements (TrueGrid; XYZ Scientific, Inc., Livemore, CA). The size and 
shape of the hydrogel injections (Figure 1, Table 1) were based on MRI reconstruction of 
injected explant tissue from a previous study. For more detail related to that experimental 
data, please see the Supplemental Material section in (Rodell et al., 2016). The geometry of 
the LV wall was based on experimental measurements from ovine hearts (Rodell et al., 
2016). For the control case, the undeformed wall thickness was approximately 1.3cm, the 
inner diameter of the endocardial wall near the equator was 4 cm, and the distance from base 
to apex was 6.4 cm.
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For the models with hydrogel injections, the control model was modified to include a 4 × 4 
pattern of 16 injections within the myocardium and the spacing between injections was 
assumed to be 1.5 cm from center to center (Figure 2a) (Rodell et al., 2016; Rodell et al., 
2015; Ryan et al., 2009). Since the injections remain as discrete plugs in the LV wall, rather 
than diffusing into the tissue, the total volume of myocardium must be conserved. This was 
accomplished by increasing the wall thickness in the injection region within each FE model. 
For the case of 300 μL injections, the wall thickness was increased by 1.5 mm to account for 
the volume added to the wall (Figure 2b). For the case of 150 μL injections, the wall 
thickness was increased by 0.5 mm (Figure 2c). The LV wall away from the injections, and 
the longitudinal dimensions, were unaltered relative to the control case. The myofiber 
orientation was assigned to vary linearly from epicardium to endocardium using the angle of 
−37 degrees to 83 degrees, respectively (McGarvey et al., 2015). A pressure of 10 mmHg 
was assigned as a boundary condition on the endocardial surface in each of the FE models, 
in order to simulate end-diastole.
2.2 Material response
The material response of the myocardium was represented using a nearly incompressible, 
transversely isotropic, hyperelastic constitutive law, which was defined using the following 
strain energy function (Guccione et al., 1991):
(1)
where Eij are the deviatoric components of the Green-Lagrange strain tensor relative to the 
myofiber coordinate system (f = fiber direction, s = cross-fiber in-plane direction, n = 
transverse-fiber direction) and J is the determinant of the deformation gradient. The diastolic 
material parameters were assigned to be C=0.51 kPa, bf =22.84, bt =3.45, and bfs =12 
(Rodell et al., 2016), while the bulk modulus was κ = 1e103 kPa. Since the model was meant 
to mimic the initial time frame after infarction, is was assumed that 30 minutes post-MI the 
myocardial properties around the injections would be roughly unchanged (Holmes et al., 
2005).
The material response of the hydrogel injections was represented using a nearly 
incompressible, isotropic, hyperelastic constitutive law, which was defined using the 
following strain energy function:
(2)
where E is the deviatoric Green-Lagrange strain tensor, tr( ) is the trace operator, and ln( ) is 
the natural log operator. The material parameters for Young’s modulus (E) were assigned in 
a range between 0.1 kPa to 100 kPa, while the Poison ratio (ν) was assigned a value of 
0.499. The range for Young’s modulus was based on measurements by Rodell et al. (Rodell 
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et al., 2016), where two formulations with a modulus of 0.8 kPa and 40 kPa were injected 
into an ovine model of MI.
3. Results
End-diastolic myofiber stress was assessed along the transmural direction, in between 
injections, for the different stiffness cases. Figure 3a shows that when the injection stiffness 
is 0.1 kPa the transmural distribution of stress is nearly unchanged compared to the 
untreated control. For a hydrogel stiffness of 25 kPa, the 150 μL injection reduced the 
myofiber stress by roughly 18.9% at the epicardium, 0% at mid-myocardium, and 21.6% at 
endocardium compared to the control (Figure 3b). However, the 300 μL injection reduced 
the myofiber stress by roughly 31% at the epicardium, 10.6% at the mid-myocardium, and 
34.7% at the endocardium compared to the control (Figure 3b). For a hydrogel stiffness of 
100 kPa, the 150 μL injection reduced the myofiber stress by roughly 39.2% at the 
epicardium, 18.3% at mid-myocardium, and 38.7% at the endocardium compared to the 
control (Figure 3c). However, the 300 μL injection reduced the myofiber stress by roughly 
56.8% at the epicardium, 36.5% at the mid-myocardium, and 55.2% at the endocardium 
compared to the control (Figure 3c).
Additionally, the average myofiber stress in the myocardium surrounding the 150 μL and 
300 μL injections, using different hydrogel stiffness values, is shown in Figure 4. When the 
injection stiffness is increased, the myofiber stress was decreased. It should be noted that the 
influence of stiffness begins to taper after 50 kPa. Figure 5 shows the average wall thickness 
as a function of injection stiffness. When the injection stiffness increased, the wall thickness 
was increased. The average wall thickness at end-diastole for the control was approximately 
1cm, while the thickness for the 150 μL injection with 25 kPa stiffness was 1.1cm and 300 
μL was 1.2cm. For the case of 150 μL injection with 100 kPa stiffness, the thickness was 
1.2cm, while 300 μL was 1.3cm. This is primarily driven by the fact that the stiffer injections 
maintained their original shape during deformation, which allows the LV wall to remain 
thick (Figure 6c and 6f). On the other hand, it can be seen that the 0.1 kPa injections 
effectively collapse in the transmural direction as the LV wall is loaded by the pressure on 
the endocardium (Figure 6a and 6d). Figure 6 also shows the distribution of end-diastolic 
myofiber stress throughout the LV wall around the 150 μL injections (Figure 6 a–c) and 300 
μL injections (Figure 6 d–f), with stiffness values of 0.1 kPa, 25 kPa and 100 kPa, 
respectively. It is clear that the myofiber stress showed a greater reduction around the 
hydrogel injection region when the volume was larger and the stiffness was higher.
Table 2 shows the end-diastolic volume (EDV) in the FE models, using various 
combinations of injection volume and stiffness. For the case of 150 μL injections, it can be 
seen that the EDV decreases, relative to the control case, by 0.6%, 2.0%, and 3.5%, using 
stiffness values of 0.1 kPa, 25 kPa and 100 kPa, respectively. For the case of 300 μL 
injections, it can be seen that the EDV decreases by 2.5%, 4.8%, and 7.0%, using stiffness 
values of 0.1 kPa, 25 kPa and 100 kPa, respectively. As noted above, the influence of 
injection stiffness on myofiber stress tapers after 50 kPa. By using stiffness values below this 
level, the decrease in EDV would be less than 5.0%.
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4. Discussion
The goal of the current study was to assess the effect of different attributes that can be tuned 
for hydrogel injections. More specifically, this work utilized a combination of previously 
measured MRI data and FE modeling to investigate how injection stiffness and volume 
influence myocardial wall stress and wall thickness. The modeling results show a clear 
reduction of myofiber stress based on the higher hydrogel injection volume. Additionally, by 
tuning the stiffness of the hydrogel, greater reductions in stress can be achieved. The current 
results indicated that stiffer hydrogel injections could reduce myofiber stress further. These 
improvements appear to taper after a stiffness of 50 kPa.
Previous studies have used FE modeling to assess the influence of biomaterial injections on 
LV function and wall stress. Kichula et al. (Kichula et al., 2014) examined the effects of a 
single hydrogel formulation, which diffused between the tissue, and a single injection 
volume on LV wall stress. It was found that the injections increased the effective stiffness of 
the tissue and decreased stress in the wall. Two other studies examined the effects of varying 
the volume of the injections on wall stress and LV ejection fraction, but did not examine the 
effects of injection stiffness. Lee et al. (Lee et al., 2014) used a patient-specific FE model to 
show that increasing the injection volume decreased both the end-diastolic and end-systolic 
stress in the myocardium. Wise et al. (Wise et al., 2016) used an animal-specific FE model 
of a rat heart to investigate a wide range of injection volumes in a model of MI. 
Interestingly, it was found that the beneficial effects of the injection began to diminish once 
the volume fraction of the injection exceeded 50% of the MI region. It should be noted that 
the volume fraction of hydrogel injection to treated myocardium in the current study was 
less than 15%. Also, the results of the current study were consistent with these previous 
studies, in terms of decreasing myofiber stress with increased injection volume. However, 
the current study showed the additional benefit of tuning the injection stiffness to reduce 
stress.
In addition to FE modeling studies, several experimental studies with large animal models 
have been conducted. Ifkovits et al. found that stiffer hydrogel injections led to a reduction 
in adverse remodeling in the MI region, i.e., the MI region was smaller in animals treated 
with stiffer hydrogels, compared with the control infarct group (Ifkovits et al., 2010). In 
work done by Plotkin et al., it was shown that hydrogels with the highest stiffness exhibited 
the best rescue of heart function (Plotkin et al., 2014), in terms of ejection fraction. Also, in 
another previous experimental study, it was shown that the higher stiffness hydrogel 
injection improved the ejection fraction after 8 weeks but not the lower stiffness hydrogel 
injection; and LVEDV measured using the higher stiffness hydrogel was smaller than the 
lower stiffness hydrogel (Rodell et al., 2016). All of these experimental studies showed 
greater benefit with a higher stiffness hydrogel, in terms of better LV geometry and function. 
This is consistent with the current FE modeling results, which indicate that the higher 
stiffness hydrogel injections are more beneficial. Additionally, previous injectable 
biomaterial studies have demonstrated that injections can increase LV wall thickness and the 
effective stiffness of the infarct region (Ifkovits et al., 2010; Landa et al., 2008; Morita et al., 
2011; Mukherjee et al., 2008; Rane and Christman, 2011; Ryan et al., 2009). This is also 
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consistent with the current results, in which a higher injection stiffness led to increased wall 
thickness due to better retention of injection shape.
One limitation of the current study is that it only focused on changes induced during the 
diastolic phase, due to hydrogel injection. Further studies are needed to assess changes in 
stress during systolic contraction. Additionally, the residual stresses that are developed 
during the injection process were not taken into account in the model. Finally, the current 
work only looked at the acute effects of the hydrogel injection post-MI. Future studies will 
include experimental data from later time points after the ventricle has been treated.
In conclusion, the current work demonstrated that FE modeling can be used to predict how 
the LV wall thickness and myofiber stress change as a function of different hydrogel 
characteristics. This approach could be used as a tool for developing tunable hydrogel 
injections and predicting stress reduction and heart function post-MI. In the future, this 
method will be used to examine more optimal injectable biomaterial properties, which 
would be valuable clinical treatments for myocardial infarction.
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Figure 1. 
Hydrogel injections are well retained and can be approximated as an ellipsoid with 
characteristic dimensions a, b, and c.
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Figure 2. 
(a) FE model of an ovine LV with 16 150 μL hydrogel injections. (b) Short axis view of the 
LV wall with 150 μL hydrogel injections. (c) Short axis view of the LV wall with 300 μL 
hydrogel injections.
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Figure 3. 
Transmural distribution of end-diastolic myofiber stress using a stiffness of (a) 0.1 kPa, (b) 
25 kPa and (c) 100 kPa, comparing between the control and injection volumes of 150 μL and 
300μL. Note: The transmural direction along which the stress was assessed is shown as a 
thick black line, in between injections, in Figure 6.
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Figure 4. 
Average end-diastolic myofiber stress surrounding the injection as a function of injection 
stiffness and volume.
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Figure 5. 
Average end-diastolic myocardial wall thickness in the injection region as a function of 
injection stiffness and volume.
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Figure 6. 
The LV end-diastolic myofiber stress distribution around (a–c) 150 μL injections and (d–f) 
300 μL injections with stiffness values of 0.1 kPa, 25 kPa and 100 kPa, respectively.
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Table 1
Ellipsoidal dimensions of the 150 μL hydrogel injection and 300 μL hydrogel injection, based on MRI data 
(Rodell et al., 2015).
150 μL 300 μL
a 5.50 mm 6.60 mm
b 3.15 mm 3.94 mm
c 2.40 mm 2.73 mm
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Table 2
End-diastolic volume in the FE model for different combinations of injection stiffness and volume. Note: The 
control end-diastolic volume is 110.1 mL.
150 μL 300 μL
0.1 kPa 109.4 mL 107.3 mL
25 kPa 107.9 mL 104.8 mL
100 kPa 106.3 mL 102.4 mL
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